AARD Butterfly Strategy
AARD (Aardvark Therapeutics, Inc. Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It functions as an agonist, targeting particular bitter taste receptors found within the gut lumen. ARD-101 is currently undergoing a Phase III clinical trial for managing excessive hunger (hyperphagia) associated with Prader-Willi Syndrome. Additionally, it is in a Phase II trial for addressing hyperphagia linked to acquired hypothalamic obesity, often a result of craniopharyngioma treatments like surgery or radiation therapy.
AARD (Aardvark Therapeutics, Inc. Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $104.5M, a beta of 4.47 versus the broader market, a 52-week range of 3.35-17.94, average daily share volume of 172K, a public-listing history dating back to 2025, approximately 22 full-time employees. These structural characteristics shape how AARD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 4.47 indicates AARD has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a butterfly on AARD?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current AARD snapshot
As of June 30, 2026, spot at $5.53, ATM IV 27.20%, expected move 7.80%. The butterfly on AARD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this butterfly structure on AARD specifically: IV rank is unavailable in the current snapshot, so regime-based timing for AARD is inferred from ATM IV at 27.20% alone, with a market-implied 1-standard-deviation move of approximately 7.80% (roughly $0.43 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AARD expiries trade a higher absolute premium for lower per-day decay. Position sizing on AARD should anchor to the underlying notional of $5.53 per share and to the trader's directional view on AARD stock.
AARD butterfly setup
The AARD butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AARD near $5.53, the first option leg uses a $5.25 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AARD chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AARD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $5.25 | N/A |
| Sell 2 | Call | $5.53 | N/A |
| Buy 1 | Call | $5.81 | N/A |
AARD butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
AARD butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on AARD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on AARD
Butterflies on AARD are pinning bets - traders use them when they expect AARD to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
AARD thesis for this butterfly
The market-implied 1-standard-deviation range for AARD extends from approximately $5.10 on the downside to $5.96 on the upside. A AARD long call butterfly is a pinning play: it pays maximum at the middle strike if AARD settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. As a Healthcare name, AARD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AARD-specific events.
AARD butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AARD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AARD alongside the broader basket even when AARD-specific fundamentals are unchanged. Always rebuild the position from current AARD chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on AARD?
- A butterfly on AARD is the butterfly strategy applied to AARD (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With AARD stock trading near $5.53, the strikes shown on this page are snapped to the nearest listed AARD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AARD butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the AARD butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 27.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AARD butterfly?
- The breakeven for the AARD butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AARD market-implied 1-standard-deviation expected move is approximately 7.80%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on AARD?
- Butterflies on AARD are pinning bets - traders use them when they expect AARD to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current AARD implied volatility affect this butterfly?
- Current AARD ATM IV is 27.20%; IV rank context is unavailable in the current snapshot.